Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure-Reference-Cited by-同舟云学术

Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure

Published:2024-09 Issue:12 Volume:84 Page:1078-1088
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Bhatt Ankeet S.^ORCID,Bhatt Deepak L.^ORCID,Steg Ph Gabriel,Szarek Michael,Cannon Christopher P.,Leiter Lawrence A.,McGuire Darren K.,Lewis Julia B.,Riddle Matthew C.,Voors Adriaan A.,Metra Marco^ORCID,Lund Lars H.,Testani Jeffrey M.,Wilcox Christopher S.,Davies Michael,Pitt Bertram,Kosiborod Mikhail N.

Publisher

Elsevier BV

Reference30 articles.

1. Physical function, frailty, cognition, depression, and quality of life in hospitalized adults ≥60 years with acute decompensated heart failure with preserved versus reduced ejection fraction;Warraich;Circ Heart Fail,2018

2. 2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee;Hollenberg;J Am Coll Cardiol,2019

3. Preferences for quality of life or survival expressed by patients with heart failure;Lewis;J Heart Lung Transplant,2001

4. Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: participant-level pooled analysis from the DAPA-HF and DELIVER trials;Bhatt;Eur J Heart Fail,2023

5. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial;Nassif;Nat Med,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Health Status With SGLT2 Inhibitors Following Worsening Heart Failure;Journal of the American College of Cardiology;2024-09